Abstract
Pruritus – itching – may not rank amongst the most common of neurological presenting symptoms but nevertheless it may on occasion be a consequence of neurological disease. Here we present a brief tabular listing of causes of pruritus which may need to be considered in the neurology clinic and which we hope may prove serviceable to practicing neurologists.
The neurobiological basis of chronic itch, a subject of ongoing research, is held to be a form of sensitisation akin to that of chronic pain, involving mechanisms in both spinal cord and brain. These mechanisms are complex and not completely characterised, involving many molecular intermediaries and neural pathways. Release of inflammatory mediators in the skin, sustained by the itch-scratch cycle, may result in increased activation (firing) of peripheral sensory fibres with resulting peripheral and central sensitisation [1]. The diversity of these mechanisms may explain why such an extensive range of neurological disorders may be associated with pruritus.
Pruritus as an isolated symptom is unlikely to be neurological in origin, and hence accompanying neurological symptoms and signs (“fellow travellers”) may direct diagnostic thinking (Table 1). This may also be informed by the distribution of pruritus, whether localised or generalised in character, for example conforming to the distribution of specific dermatomes or cutaneous nerves (Table 2). Of course, therapeutic drug use also requires consideration, whether or not relevant to any underlying neurological condition (Table 3).
Table 1: Causes of pruritus
1. Dermatological: e.g. atopic dermatitis, psoriasis, prurigo nodularis.
2. Neurological: the same conditions that can cause neuropathic pain can also cause neuropathic/neurogenic itch.
a. Central: pruritus of central cause is rare [3].
b. Peripheral:
3. Systemic:
a. Metabolic/endocrine: CKD, hepatobiliary diseases (e.g. primary biliary cirrhosis, although pruritus may occur with or without cholestasis), hyperparathyroidism, hyper/hypothyroidism, ferropenia, diabetes, perimenopause, pregnancy.
b. Infections: HIV, parasitosis including helminthosis, viral hepatitis.
c. Haematological conditions: polycythaemia vera, myeloproliferative diseases, lymphoma.
d. Malignancies (‘paraneoplastic itch’): especially haematological and gastrointestinal.
e. Drug-induced (see Table 3)
4. Psychogenic/psychosomatic: in context of depression, anxiety, delusional disorders (e.g. Ekbom’s syndrome or delusional parasitosis), eating disorders.
5. Mixed, other, unknown origin.
Little information seems to be available to indicate whether treatment of the underlying neurological condition may result in abatement of pruritus, or whether the use of symptomatic agents may be needed. An increasing number of pharmacological options for the modulation of the neuro-immune pathways thought to underpin pruritus in spinal cord and brain are available, and targeted cognitive behavioural therapy may also be tried, as for chronic pain [2].
Table 2: Mononeuropathies of presumed or possible compressive origin which may cause localised pruritus
| Nerve(s) involved | Distribution | Causes | Other | |
| Notalgia paraesthetica [14] | Dorsal branches of T2-T6 | Medial scapula within the middle/upper back | Unknown: ?entrapment | Hyperpigmentation due to chronic scratching is common |
| Meralgia paraesthetica [15] | Femoral cutaneous nerve of thigh | Anterior/exterior aspect of thigh | Compression by inguinal ligament, other | More common in obesity |
| Cheiralgia paraesthetica [16,17] | Superficial radial nerve | Dorsolateral aspect of hand | Wrist constriction (watch, handcuffs), injury | |
| Brachioradial pruritus [18] | Cervical radiculopathy has been proposed; role unclear | Dorsolateral arm/forearm | Unknown | Anecdotal reports of improvement after decompressive surgery, epidural steroid injections |
Table 3: Drugs that may induce or maintain chronic pruritus (adapted from European S2k guideline on chronic pruritus) [2].
| CLASS OF DRUG | SUBSTANCES (EXAMPLES) |
| Anti-arrhythmic agents | Amiodarone, disopyramide, flecainide |
| Antibiotics | Amoxicillin, ampicillin, cefotaxime, ceftriaxone, chloramphenicol, ciprofloxacin, clarithromycin, clindamycin, cotrimoxazole, erythromycin, gentamicin, metronidazole, minocycline, ofloxacin, penicillin, tetracycline |
| Antidepressants | Amitryptyline, citalopram, clomipramine, desipramine, doxepin, fluoxetine, fluvoxamine, imipramine, lithium, maprotiline, mirtazapine, nortriptyline, paroxetine, sertraline |
| Antidiabetic drugs | Glimepiride, metformin, tolbutamide |
| Antihypertensive drugs | Clonidine, doxazosin, hydralazine, methyldopa, minoxidil, prazosin, reserpine ACE inhibitors: captopril, enalapril, lisinopril Angiotensin II antagonists: irbesartan, telmisartan, valsartan Betablockers: acebutolol, atenolol, bisoprolol, metoprolol, nadolol, pindolol, propranolol Calcium antagonists: amlodipine, diltiazem, felodipine, isradipine, nifedipine, nimodipine, nisoldipine, verapamil Diuretics: amiloride, furosemide, hydrochlorothiazide, spironolactone |
| Anticonvulsants | Carbamazepine, clonazepam, gabapentin, lamotrigine, phenobarbital, phenytoin, topiramate, valproic acid |
| Anti-inflammatory drugs | Acetylsalicylic acid, celecoxib, diclofenac, ibuprofen, indometacin, ketoprofen, naproxen, piroxicam |
| Bronchodilators, other | Aminophylline, doxapram, ipratropium bromide, salmeterol, terbutaline |
| Hormones | Clomifene, danazol, oral contraceptives, oestrogens, progesterone, steroids, testosterone and derivates, tamoxifen |
| Immunosuppressive drugs | Cyclophosphamide, cyclosporin, methotrexate, mycophenolate mofetil, tacrolimus, thalidomide |
| Antilipids | Clofibrate, fenofibrate, fluvastatin, lovastatin, pravastatin, simvastatin |
| Neuroleptics | Chlorpromazine, haloperidol, risperidone |
| Tranquilisers | Alprazolam, chlordiazepoxide, lorazepam, oxazepam, prazepam |
| Uricostatics | Allopurinol, colchicine, probenecid, tiopronin |
| Sign up for ACNR email updates – the latest articles in your inbox |
References
- Mahmoud O, Oladipo O, Mahmoud RH, Yosipovitch G. Itch: from the skin to the brain – peripheral and central neural sensitization in chronic itch. Front Mol Neurosci. 2023;16:1272230. https://doi.org/10.3389/fnmol.2023.1272230
- Weisshaar E, Muller S, Szepeitowski JC et al. European S2k Guideline on chronic pruritus. Acta Derm Venereol. 2025;105:adv44220. https://doi.org/10.2340/actadv.v105.44220
- Canavero S, Bonicalzi V, Massa-Micon B. Central neurogenic pruritus: a literature review. Acta Neurol Belg. 1997;97:244-247.
- He M, Wu L, Huang D, Yau V, Yu S. Pruritus in neuromyelitis optica spectrum disorders and multiple sclerosis. J Clin Neurosci. 2020;79:108-112. https://doi.org/10.1016/j.jocn.2020.07.022
- Zhao S, Mutch K, Elsone L, Miller J, Jacob A. An unusual case of “itchy paralysis”: neuromyelitis optica presenting with severe neuropathic itch. Pract Neurol. 2015;15:149-151. https://doi.org/10.1136/practneurol-2014-000936
- Magilner D. Localized cervical pruritus as the presenting symptom of a spinal cord tumor. Pediatr Emerg Care. 2006;22:746-747. https://doi.org/10.1097/01.pec.0000238735.14532.2e
- Johnson RE, Kanigsberg ND, Jimenez CL. Localized pruritus: a presenting symptom of a spinal cord tumor in a child with features of neurofibromatosis. J Am Acad Dermatol. 2000;43:958-961. https://doi.org/10.1067/mjd.2000.104000
- Soltani-Arabshahi R, Vanderhooft S, Hansen CD. Intractable localized pruritus as the sole manifestation of intramedullary tumor in a child: case report and review of the literature. JAMA Dermatol. 2013;149:446-449. https://doi.org/10.1001/jamadermatol.2013.2032
- Andreev VC, Petkov I. Skin manifestations associated with tumours of the brain. Br J Dermatol. 1975;92:675-678.
https://doi.org/10.1111/j.1365-2133.1975.tb03148.x - Fardel MA, Brenaut E, Guellec D, Etienne M, Fouchard M, Seizeur R, Misery L. Pruritus and brain tumours: A prospective and descriptive study. Skin Health Dis. 2022;3:e202. https://doi.org/10.1002/ski2.202
- Ganguly S, Krishna CV, Parmar NV, Kuruvila S, Phansalkar DS. Unilateral pruritus following stroke. Indian J Dermatol Venereol Leprol. 2015;81:186-188. https://doi.org/10.4103/0378-6323.152294
- Curtis AR, Oaklander AL, Johnson A, Yosipovitch G. Trigeminal trophic syndrome from stroke: an under-recognized central neuropathic itch syndrome. Am J Clin Dermatol. 2012;13:125-128. https://doi.org/10.2165/11594060-000000000-00000
- Cohen OS, Chapman J, Lee H, Nitsan Z, Appel S, Hoffman C, Rosenmann H, Korczyn AD, Prohovnik I. Pruritus in familial Creutzfeldt-Jakob disease: a common symptom associated with central nervous system pathology. J Neurol. 2011;258:89-95. https://doi.org/10.1007/s00415-010-5694-1
- Robinson C, Downs E, de la Caridad Gomez Y, Nduaguba C, Woolley P, Varrassi G, Gill J, Simopoulos TT, Viswanath O, Yazdi CA. Notalgia paresthetica review: update on presentation, pathophysiology, and treatment. Clin Pract. 2023;13:315-325. https://doi.org/10.3390/clinpract13010029
- de Ruiter GCW, Oosterhuis JWA, Vissers TFH, Kloet A. Unusual causes for meralgia paresthetica: systematic review of the literature and single center experience. Neurosurg Rev. 2023;46:107. https://doi.org/10.1007/s10143-023-02023-2
- Kesserwani H. Cheiralgia paresthetica or superficial radial sensory mononeuropathy: a simple diagnosis, a simple solution, and a side note on the pathophysiology of the Tinel sign. Cureus. 2020;12:e10224. https://doi.org/10.7759/cureus.10224
- Shields LBE, Iyer VG, Zhang YP, Shields CB. Etiological study of superficial radial nerve neuropathy: series of 34 patients. Front Neurol. 2023;14:1175612. https://doi.org/10.3389/fneur.2023.1175612
- Shields LB, Iyer VG, Zhang YP, Shields CB. Brachioradial pruritus: clinical, electromyographic, and cervical MRI features in nine patients. Cureus. 2022;14:e21811. https://doi.org/10.7759/cureus.21811

